LifeMD, Inc. - Common Stock (LFMD)

LifeMD stock plunges after Q3 2025 earnings miss analyst estimates on both revenue and EPS, triggering a major sell-off.

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Here's a look at the details from LifeMD's Q3 earnings report.

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout.

Hims & Hers Health (NYSE: HIMS) became a significant after-hours mover on Monday, November 3, 2025, following the release of its third-quarter 2025 financial results and the pivotal announcement of renewed discussions with Novo Nordisk A/S (NYSE: NVO) regarding the potential distribution of Wegovy. While the telehealth platform reported a

The convergence of Artificial Intelligence and longevity research is heralding a transformative era, often termed "Longevity AI." This interdisciplinary field leverages advanced computational power to unravel the complexities of human aging, with the ambitious goal of extending not just lifespan, but more crucially, "healthspan"—the period of life spent in good health. At the forefront of [...]

Telehealth companies are getting a fresh infusion of business thanks to obesity drugs. Find out which stocks are benefiting.

Discover the stocks with unexpected trading volume in today's session on the US markets.

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

The company is struggling with several headwinds as it works to develop its obesity plan.

The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.